title: Therapy-related myelodysplastic syndrome after alkylating agents and platinum-based therapy for malignant melanoma.
authors.affiliation: Department Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
authors.forename: Rirei
authors.initials: R
authors.lastname: Nin-Asai
authors.forename: Masaki
authors.initials: M
authors.lastname: Sawada
authors.forename: Takaaki
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Shigeki
authors.initials: S
authors.lastname: Saito
authors.forename: Kenji
authors.initials: K
authors.lastname: Yokota
authors.forename: Masashi
authors.initials: M
authors.lastname: Akiyama
mesh_terms: D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D009190:Myelodysplastic Syndromes / Q000139:chemically induced*; D015376:Nimustine / Q000009:adverse effects; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D015376:Nimustine; D003606:Dacarbazine; D002945:Cisplatin